CCIZX | TEFQX | CCIZX / TEFQX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 14 years | 25 years | - |
Gain YTD | 3.298 | 1.847 | 179% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 2000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.6B | 41.8M | 34,928% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 17.79 | -15.16 | -117% |
Returns for 3 years | 10.28 | -72.39 | -14% |
Returns for 5 years | 63.08 | -71.76 | -88% |
Returns for 10 years | 164.56 | -51.69 | -318% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ONEQ | 77.40 | 1.26 | +1.65% |
Fidelity Nasdaq Composite ETF | |||
ADME | 47.63 | 0.45 | +0.94% |
Aptus Drawdown Managed Equity ETF | |||
DBEM | 24.90 | 0.12 | +0.49% |
Xtrackers MSCI Em Mkts Hdg Eq ETF | |||
XMLV | 61.84 | 0.08 | +0.14% |
Invesco S&P MidCap Low Volatility ETF | |||
FTXH | 26.92 | -0.20 | -0.74% |
First Trust Nasdaq Pharmaceuticals ETF |